mhurhangee/ep-ind-claims huggingface dataset:
A congestion control system, comprising: an operations maintenance center device configured to receive a congestion status report of a base station and send the congestion status report of the base station to a policy charging and control rule function entity through a reporting interface; and the policy charging and control rule function entity configured to perform traffic limiting or service limiting on a user in a cell where congestion occurs according to a congestion status in the congestion status report. an operations maintenance center device configured to receive a congestion status report of a base station and send the congestion status report of the base station to a policy charging and control rule function entity through a reporting interface; and the policy charging and control rule function entity configured to perform traffic limiting or service limiting on a user in a cell where congestion occurs according to a congestion status in the congestion status report.
Flexible payload for satellite comprising: - Main uplink antenna means configured to receive at least a main uplink signal over a main coverage area; - Reconfigurable uplink antenna means configured to receive a complementary uplink signal (S C1) over a complementary coverage area (C C1); - Command means configured to define the complementary coverage area (C C1) of the reconfigurable uplink antenna means so that it corresponds to the main coverage area without an interfered coverage area (Ci); characterized by - Agile converting means configured to generate a spectral hole in the bandwidth of the main uplink signal. - Main uplink antenna means configured to receive at least a main uplink signal over a main coverage area; - Reconfigurable uplink antenna means configured to receive a complementary uplink signal (S C1) over a complementary coverage area (C C1); - Command means configured to define the complementary coverage area (C C1) of the reconfigurable uplink antenna means so that it corresponds to the main coverage area without an interfered coverage area (Ci); - Agile converting means configured to generate a spectral hole in the bandwidth of the main uplink signal.
A method for producing one or more radio-frequency resonant patterns on a printed circuit comprising multiple layers comprising a step of milling cutting one or more resonant patterns directly into the printed circuit whilst preserving means for mechanically securing the resonant patterns to said printed circuit, and in combination at least the following steps: a) chemically etching the internal layers of the multilayer printed circuit, after which the printed circuit is pressed, b) producing multiple holes necessary for obtaining conductive metallized vias, c) metallizing the metalized vias, d) chemically etching the external layers of said printed circuit, e) one or more of the following elements are produced by milling: external cutting of the printed circuit, or of the internal contours, the step of milling the contours of the resonant patterns being carried out simultaneously with step b), and the method further comprising a step of metallizing the edges of the contours of the resonant patterns, being carried out simultaneously with step c). a) chemically etching the internal layers of the multilayer printed circuit, after which the printed circuit is pressed, b) producing multiple holes necessary for obtaining conductive metallized vias, c) metallizing the metalized vias, d) chemically etching the external layers of said printed circuit, e) one or more of the following elements are produced by milling: external cutting of the printed circuit, or of the internal contours, the step of milling the contours of the resonant patterns being carried out simultaneously with step b), and the method further comprising a step of metallizing the edges of the contours of the resonant patterns, being carried out simultaneously with step c).
A dental hand piece for spraying powder comprising: a pellet storage part for storing a pellet; a powder generation part for generating powder by grinding the stored pellet; and a spray port for spraying the powder generated in the powder generation part, characterized in that the powder generation part comprises a linear motion actuator for urging the pellet in the pellet storage part, a grinder abutting on the pellet urged by the linear motion actuator, and a vibrator for vibrating the grinder. a pellet storage part for storing a pellet; a powder generation part for generating powder by grinding the stored pellet; and a spray port for spraying the powder generated in the powder generation part, characterized in that the powder generation part comprises a linear motion actuator for urging the pellet in the pellet storage part, a grinder abutting on the pellet urged by the linear motion actuator, and a vibrator for vibrating the grinder.
A pharmaceutical composition comprising: (i) at least one bacteriophage strain(s) capable of producing a lytic infection in an adherent-invasive Escherichia coli strain; and (ii) a pharmaceutically acceptable carrier; for use in the treatment of inflammatory bowel disease, wherein the composition comprises at least one of the bacteriophage strain P1 deposited with the French National Collection of Microorganisms at the Institut Pasteur under Accession Number CNCM I-4694 or a variant thereof, wherein the variant has the same lytic activity and the same phenotypic characteristics as said bacteriophage strain P1, the bacteriophage strain P2 deposited with the French National Collection of Microorganisms at the Institut Pasteur under Accession Number CNCM I-4695 or a variant thereof, wherein the variant has the same lytic activity and the same phenotypic characteristics as said bacteriophage strain P2, the bacteriophage strain P3 deposited with the French National Collection of Microorganisms at the Institut Pasteur under Accession Number CNCM I-4696 or a variant thereof, wherein the variant has the same lytic activity and the same phenotypic characteristics as said bacteriophage strain P3, the bacteriophage strain P4 deposited with the French National Collection of Microorganisms at the Institut Pasteur under Accession Number CNCM 1-4697 or a variant thereof, wherein the variant has the same lytic activity and the same phenotypic characteristics as said bacteriophage strain P4, the bacteriophage strain P5 deposited with the French National Collection of Microorganisms at the Institut Pasteur under Accession Number CNCM I-4698 or a variant thereof, wherein the variant has the same lytic activity and the same phenotypic characteristics as said bacteriophage strain P5, the bacteriophage strain P6 deposited with the French National Collection of Microorganisms at the Institut Pasteur under Accession Number CNCM I-4699 or a variant thereof, wherein the variant has the same lytic activity and the same phenotypic characteristics as said bacteriophage strain P6, the bacteriophage strain P8 deposited with the French National Collection of Microorganisms at the Institut Pasteur under Accession Number CNCM I-4700 or a variant thereof, wherein the variant has the same lytic activity and the same phenotypic characteristics as said bacteriophage strain P8 and the bacteriophage strain CLB_P2 deposited with the French National Collection of Microorganisms at the Institut Pasteur under Accession Number CNCM I-4675 or a variant thereof, wherein the variant has the same lytic activity and the same phenotypic characteristics as said bacteriophage strain CLB_P2. (i) at least one bacteriophage strain(s) capable of producing a lytic infection in an adherent-invasive Escherichia coli strain; and (ii) a pharmaceutically acceptable carrier;
An isolated optimized gene modified to increase GC sequences and reduce cis motifs relative to a wild type FIX gene, wherein the optimized gene for FIX has a nucleotide sequence of SEQ ID NO: 7.
A blood separation medium comprising - a fibrous web formed by first fibers at least a part of which are selected from glass microfibers, non-fibrillated fibers having an affinity for red blood cells and combinations thereof, and second fibers selected from fibrillated fibers; - said fibrous web containing a polymeric, hydrophilic binder, a wetting agent and a salt, said salt being an ionic compound that dissociates in water which is selected from the group of salts capable of increasing the tonicity of blood plasma; and wherein said fibrous web has a mean flow pore size smaller than the average size of red blood cells. - a fibrous web formed by first fibers at least a part of which are selected from glass microfibers, non-fibrillated fibers having an affinity for red blood cells and combinations thereof, and second fibers selected from fibrillated fibers; - said fibrous web containing a polymeric, hydrophilic binder, a wetting agent and a salt, said salt being an ionic compound that dissociates in water which is selected from the group of salts capable of increasing the tonicity of blood plasma; and
A process for the production of a surfactant-containing liquid cleaning agent with a pH value of 7 to 8 and a surfactant content of 5 to 40% by weight, containing a) at least one fatty alcohol ether sulfate b) at least one amine oxide and/or one betaine where the weight ratio of fatty alcohol ether sulfate to amine oxide/betaine is from 3:2 to 10:1, comprising the sequential steps of i) providing a solvent system having a pH outside the range of from 7 to 8; ii) introducing the fatty alcohol ether sulfate into the solvent system having a pH outside the range of from 7 to 8 and mixing it subsequently; (iii) introducing further active ingredients and mixing them in; (iv) adjusting the pH of the resulting mixture to a pH of 7 to 8, - in step (i) the pH being adjusted to values above 10 by adding an organic salt; - in step (ii) amine oxide and/or betaine being introduced before the fatty alcohol ether sulfate is introduced. a) at least one fatty alcohol ether sulfate b) at least one amine oxide and/or one betaine i) providing a solvent system having a pH outside the range of from 7 to 8; ii) introducing the fatty alcohol ether sulfate into the solvent system having a pH outside the range of from 7 to 8 and mixing it subsequently; (iii) introducing further active ingredients and mixing them in; (iv) adjusting the pH of the resulting mixture to a pH of 7 to 8, - in step (i) the pH being adjusted to values above 10 by adding an organic salt; - in step (ii) amine oxide and/or betaine being introduced before the fatty alcohol ether sulfate is introduced.
Valve unit adapted to connect a water supply network to a primary circuit, the valve unit comprising a first body that includes a conduit for the inlet of water from the supply network, a second body that includes an outlet conduit adapted to conduct the inlet water to the primary circuit, a disconnection conduit adapted to disconnect the communication between the first body and the second body, opening/closure means (24;50) for the passage of water from the inlet conduit to the second body, and a connector by means of which the first body is arranged coupled to the second body, said connector comprising a base from which extends a threaded end for its coupling to one of the bodies (10,20) and a coupling that is housed in the other body (10,20), the connector being fixed to said body (10,20) by means of quick fixing means, the opening/closure means (24;50) being arranged in a housing of the first body, the opening/closure means (24;50) including a rod (25;52) that includes at one end a sealing member (6;51), and an actuator (29;53) operable by the user and coupled to the rod (25;52), characterised in that the sealing member (6; 51) of the rod (25; 52), in normal operating conditions of the primary circuit, closes the passage of water from the first body to the second body, the opening/closure means (24;50) comprising a support (28;54) that is arranged inserted in one end of the housing of the first body, a spring member (23;55) that acts on the rod (25;52), the spring member (23;55) being arranged concentric to the rod (25;52), and retention means that comprise a flat surface (29b;58c) of the actuator (29;53) that cooperates with a flat surface (28b;54c) of the support (28;54) in a position that allows the passage of water from the first body to the second body, locking the displacement of the rod (25;52), wherein the actuator (29; 53), by means of a rotation movement, moves the rod (25;52) along the housing against the spring member (23; 55) compressing it, connecting the inlet conduit with the outlet conduit, the spring member (23; 55) moving the rod (25;52) in order to close the passage of water from the first body to the second body when the user stops activating the rod (25;52) or when the user unlocks the retention means.
An image forming apparatus for forming an image on a recording medium based on document data, the apparatus comprising: a speech unit for communicating information about the document data to a user via speech; and characterised by a confidentiality determining unit for determining whether the document data is confidential; wherein the information communicated by the speech unit is dependent on whether or not it is determined that the document data is confidential. a speech unit for communicating information about the document data to a user via speech; and characterised by a confidentiality determining unit for determining whether the document data is confidential; wherein the information communicated by the speech unit is dependent on whether or not it is determined that the document data is confidential.
An agricultural vehicle, comprising: a chassis; a cleaning system carried by said chassis including at least one sieve (141/142/143) and configured to clean crop material; and an unloader carried by said chassis and supplied with cleaned crop material from said cleaning system, said unloader including: a roller; a belt wrapped around said roller; an oblong housing at least partially enclosing said belt; and said belt defining a conveying side and a return side opposite said conveying side; characterized in that said oblong housing includes a first U-shaped surface which curves said conveying side of said belt during rotation of said roller and a second U-shaped surface which curves said return side of said belt during rotation of said roller. a chassis; a cleaning system carried by said chassis including at least one sieve (141/142/143) and configured to clean crop material; and an unloader carried by said chassis and supplied with cleaned crop material from said cleaning system, said unloader including: a roller; a belt wrapped around said roller; an oblong housing at least partially enclosing said belt; and said belt defining a conveying side and a return side opposite said conveying side; a roller; a belt wrapped around said roller; an oblong housing at least partially enclosing said belt; and said belt defining a conveying side and a return side opposite said conveying side;
Friction clutch for coupling a drive shaft of a motor vehicle engine to at least one transmission input shaft, having an input part which can be coupled to the drive shaft in order to introduce a torque of the drive shaft, an output part which can be coupled to the transmission input shaft in order to output a torque, a pressing part which can be moved axially relative to the input part and to the output part in order to press the output part to the input part in a frictionally locking manner, and a restoring spring which is configured as a leaf spring in order to position the pressing part into a defined starting position relative to the input part, it being possible for at least part of the torque which is transmitted from the input part to be transmitted via the restoring spring, and the restoring spring running substantially in a tangential direction between a torque introduction point and a torque output point and running obliquely by an angle of attack with respect to a radial plane of the friction clutch, characterized in that an actuating system which acts on the pressing part is provided in order to move the pressing part relative to the input part, and at least part of the axial extent of the actuating system is covered by the pressing part as viewed radially to the inside.
A single facer comprising: a first corrugating roll and a second corrugated roll being intermeshed with each other to shape a fluted corrugated medium (e) and each having a fluted outer periphery surface; a gluing unit that applies glue to a flute tip of the fluted corrugated medium (e); and a pressure unit that presses the glued fluted corrugated medium (e) and a back liner (f) to bond them together, in conjunction with the first corrugating roll located downstream of the second corrugating roll in a corrugated medium feed direction, characterized in that a curvature of a curved surface of a crest on the second corrugating roll is configured to be greater than a curvature of a curved surface of a crest on the first corrugating roll. a first corrugating roll and a second corrugated roll being intermeshed with each other to shape a fluted corrugated medium (e) and each having a fluted outer periphery surface; a gluing unit that applies glue to a flute tip of the fluted corrugated medium (e); and a pressure unit that presses the glued fluted corrugated medium (e) and a back liner (f) to bond them together, in conjunction with the first corrugating roll located downstream of the second corrugating roll in a corrugated medium feed direction, characterized in that a curvature of a curved surface of a crest on the second corrugating roll is configured to be greater than a curvature of a curved surface of a crest on the first corrugating roll.
A secondary battery, comprising: a case, comprising a base plate and a side plate connected with the base plate, wherein the base plate and the side plate form a receiving hole and an opening in communication with the receiving hole, the opening is arranged opposite to the base plate in an axial direction of the receiving hole, and the base plate has a thickness larger than that of the side plate; a cap assembly, sealingly connected with the side plate to close the opening; and an electrode assembly, disposed in the receiving hole and comprising two or more electrode units, wherein the electrode unit comprises a first electrode plate, a second electrode plate and a separator, and is formed by winding the first electrode plate, the second electrode plate and the separator and has a wide side and a narrow side, the two or more electrode units are stacked in the axial direction, and each electrode unit is arranged with the wide side opposite to the base plate and the narrow side toward the side plate. a case, comprising a base plate and a side plate connected with the base plate, wherein the base plate and the side plate form a receiving hole and an opening in communication with the receiving hole, the opening is arranged opposite to the base plate in an axial direction of the receiving hole, and the base plate has a thickness larger than that of the side plate; a cap assembly, sealingly connected with the side plate to close the opening; and an electrode assembly, disposed in the receiving hole and comprising two or more electrode units, wherein the electrode unit comprises a first electrode plate, a second electrode plate and a separator, and is formed by winding the first electrode plate, the second electrode plate and the separator and has a wide side and a narrow side, the two or more electrode units are stacked in the axial direction, and each electrode unit is arranged with the wide side opposite to the base plate and the narrow side toward the side plate.
A computer-implemented method for providing information for selecting an anticancer agent using individual genome sequence variation, which comprises: a step of obtaining one or more sequence variations of a patient in genes determined to be involved in the pharmacodynamics or pharmacokinetics of an anticancer agent from individual genome sequence information; a step of calculating a protein damage score using [Equation 2], wherein S g v 1,..., v n = ∏ i = 1 n v i w i 1 / ∑ i = 1 n w i wherein Sg is the protein damage score of a protein encoded by a gene g, n is the number of the one or more sequence variations of the gene g, vi is a gene sequence variation score of an i th gene sequence variation, and w i is a weighting assigned to the gene sequence variation score vi of the i th gene sequence variation; and a step of calculating an individual drug score using [Equation 4], wherein S d g 1,..., g n = ∏ i = 1 n g i w i 1 / ∑ i = 1 n w i wherein S d is the individual drug score of an anticancer agent d, n is a number of proteins encoded by one or more genes involved in the pharmacodynamics or pharmacokinetics of the anticancer agent d, gi is a protein damage score of a protein encoded by one or more genes involved in the pharmacodynamics or pharmacokinetics of the anticancer agent d, and w i is a weighting assigned to the protein damage score gi of the protein encoded by one or more genes involved in the pharmacodynamics or pharmacokinetics of the anticancer agent d; and providing information for selecting an anticancer agent based on the calculation of the individual drug score. a step of obtaining one or more sequence variations of a patient in genes determined to be involved in the pharmacodynamics or pharmacokinetics of an anticancer agent from individual genome sequence information; a step of calculating a protein damage score using [Equation 2], wherein S g v 1,..., v n = ∏ i = 1 n v i w i 1 / ∑ i = 1 n w i wherein Sg is the protein damage score of a protein encoded by a gene g, n is the number of the one or more sequence variations of the gene g, vi is a gene sequence variation score of an i th gene sequence variation, and w i is a weighting assigned to the gene sequence variation score vi of the i th gene sequence variation; and a step of calculating an individual drug score using [Equation 4], wherein S d g 1,..., g n = ∏ i = 1 n g i w i 1 / ∑ i = 1 n w i wherein S d is the individual drug score of an anticancer agent d, n is a number of proteins encoded by one or more genes involved in the pharmacodynamics or pharmacokinetics of the anticancer agent d, gi is a protein damage score of a protein encoded by one or more genes involved in the pharmacodynamics or pharmacokinetics of the anticancer agent d, and w i is a weighting assigned to the protein damage score gi of the protein encoded by one or more genes involved in the pharmacodynamics or pharmacokinetics of the anticancer agent d; and providing information for selecting an anticancer agent based on the calculation of the individual drug score.
An aircraft monitoring system comprising: targets associated with a wing of an aircraft; a camera system configured to generate images of the targets on the wing during operation of the aircraft; and a monitor configured to measure a movement of the targets using the images characterized in that the monitor is further configured to calculate stress in the wing based on the movement of the targets; wherein the monitor is further configured to perform, with the calculation of stress, an action selected from initiating a maneuver and halting a maneuver. targets associated with a wing of an aircraft; a camera system configured to generate images of the targets on the wing during operation of the aircraft; and a monitor configured to measure a movement of the targets using the images characterized in that the monitor is further configured to calculate stress in the wing based on the movement of the targets; wherein the monitor is further configured to perform, with the calculation of stress, an action selected from initiating a maneuver and halting a maneuver.